Predicting response to CAR T-cell therapy in CLLMay 1, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Team identifies 5 subtypes of DLBCLMay 1, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
CHMP recommends approval for generic carmustineApril 28, 2018Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Radioimmunoconjugate shows activity in NHLApril 27, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
CDK inhibitor synergizes with venetoclax in CLLApril 26, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
FDA places tazemetostat trials on partial holdApril 25, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Improving education for pediatric cancer caregiversApril 25, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHematology NursingPediatrics
Exercise linked to risk of death in cancer patientsApril 24, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingRelated Issues
Art education benefits blood cancer patientsApril 23, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingTransplantationAML
Inhibitor outperforms rivals in leukemia, lymphomaApril 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLNon-Hodgkin LymphomaAggressive Lymphomas
Team uses iPSCs to create ‘universal’ CAR T cellsApril 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive Lymphomas
Groups launch open portal for cancer modelsApril 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
Research reveals new subtypes of DLBCLApril 12, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Generic antiemetic now available in USApril 12, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Tazemetostat exhibits antitumor activity in phase 1 trialApril 11, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
